AzTrials
AzTrials

DepressionNCT07202325

Self-Help Intervention for Post 9/11 Veterans With Depression or PTSD Symptoms

A study testing Resilience Training for Veterans (REST-V) and Usual resources in people with Depression and Stress Disorders, Post-Traumatic, run by VA Office of Research and Development at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

It is important to provide support and resources for the many post-9/11 Veterans with mental health symptoms and poor psychosocial functioning who do not engage in psychotherapy. One of the biggest reasons post-9/11 Veterans do not seek treatment is a preference to handle problems on their own. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Depression, Stress Disorders, Post-Traumatic
What is being tested?
Resilience Training for Veterans (REST-V) and Usual resources
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
2 sitesUnited States
Study dates
1 Mar 2027to 30 Aug 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Veteran age >= 18 years who served on or after September 11, 2001
  • Enrolled at Syracuse or Durham VA Healthcare System (had an encounter in primary care or Military 2VA clinic in past 24 months)
  • Screen positive for current symptoms of MDD (PHQ-2) or PTSD (PC-PTSD-5)
  • Report current functional impairment (PHQ-9 item 10)

Who cannot join

  • Inability to communicate in English
  • Visual impairment that precludes reading self-help materials
  • Hearing impairment that precludes completing telephone assessments
  • Cognitive impairment that precludes providing informed consent
  • Serious mental illness (diagnosis of bipolar disorder or schizophrenia spectrum and other psychotic disorders)
  • Engaged in psychotherapy/counseling (>= 2 outpatient therapy visits in past 90 days, scheduled outpatient therapy visit in upcoming 30 days that intends to attend, or psychiatric hospitalization in past 90 days)
  • Started or had dosage change in psychotropic medication in the past 4 weeks
  • At imminent risk of suicide or has active high-risk for suicide flag

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites
  • Durham VA Medical Center, Durham, NC

    Durham, North Carolina, 27705-3875

    Patrick Calhoun, PhD, 919-286-0411 ext. 7970, Patrick.Calhoun2@va.gov

  • Syracuse VA Medical Center, Syracuse, NY

    Syracuse, New York, 13210-2716

    Robyn L Shepardson, PhD, (315) 425-4400 ext. 53519, Robyn.Shepardson@va.gov

    Robyn L. Shepardson, PhD

Other trials in United States

About this study

Official title: A Self-Help Intervention to Improve Functioning, Symptoms, and Treatment Utilization Among Non-Treatment Engaged Post 9/11 Veterans With Depression or PTSD Symptoms

It is important to provide support and resources for the many post-9/11 Veterans with mental health symptoms and poor psychosocial functioning who do not engage in psychotherapy. One of the biggest reasons post-9/11 Veterans do not seek treatment is a preference to handle problems on their own. This study examines a self-help intervention that teaches Veterans healthy coping strategies they can use on their own and how to seek out recovery support services such as mental health treatment or whole-person care if they decide to do so in the future. This study will compare the impact of self-help and standard resources at improving mental health and resource utilization. Two hundred Veterans will complete 6 brief assessments across 40 weeks.

Read the detailed description

Many post-9/11 Veterans experience impaired psychosocial functioning, due in part to high rates of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD). Less than half of post-9/11 Veterans with these conditions seek mental health treatment, with key barriers being a preference to self-manage and lack of time. Veterans also report difficulty navigating the overwhelming array of resources available. To address this gap for post-9/11 Veterans with unmet mental health needs, the investigators developed a self-help intervention to provide skills for healthy self-management as well as curated guidance on recovery support services that address mental health and broader whole-person functional challenges. The investigators will compare the self-help intervention to a control condition of standard printed resource/treatment information as is provided in usual care. The objective of this clinical trial is to evaluate the efficacy of the intervention (vs. control) at improving psychosocial functional impairment, mental health outcomes, and utilization of cognitive-behavioral coping skills and recovery support services. The investigators will also explore use of coping skills and recovery support services as potential mediators of the intervention. A total of 200 Veterans from the Syracuse and Durham VA healthcare system will complete validated measures in 6 assessments over 40 weeks.

Being tested
Resilience Training for Veterans (REST-V), Usual resources
Keywords
Self-Management, Depression, Post Traumatic Stress Disorder, Veterans, Psychosocial Functioning, Clinical Trial, Psychological Intervention, Self-Help
Medical subject headings
Depression, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resilience Training for Veterans (REST-V)Behavioural

    A 6-week self-help intervention tailored for post-9/11 Veterans offering guidance on cognitive-behavioral self-management coping strategies plus when and how to access recovery support services including mental health treatment. Materials are sent once a week for 6 weeks, and participants can opt to receive weekly reminder text messages or up to 3 brief telephone support calls.

  • Usual resourcesOther

    Standard printed resource/treatment information provided in VHA usual care to post-9/11 Veterans. Covers similar domains as the intervention materials and provides information on a variety of VA and community resources for Veterans. Materials are sent once.

Study groups in NCT07202325
Study groupRoleWhat they receive
Intervention conditionExperimentalSelf-help intervention
Receives: Behavioral: Resilience Training for Veterans (REST-V)
Control conditionActive comparatorUsual resources
Receives: Other: Usual resources

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inventory of Psychosocial Functioning (IPF)

    An 80-item self-report measure of mental-health related psychosocial functional impairment over the past 30 days. The IPF yields domain scores for up to 7 domains (e.g., work, family, self care), with only those domains relevant for the individual being scored, and an overall score. The overall IPF score is an unweighted average of all calculated domain scores, scaled to a range of 0-100. Higher scores indicate greater psychosocial functional impairment (i.e., lower scores = better functioning).

    Measured: Weeks 0 to 8, 24, and 40

Secondary outcomes (6)
  1. Brief Symptom Inventory-18 (BSI-18) Global Severity Index

    An 18-item self-report measure of general psychological distress over the past 7 days serves as a cross-cutting mental health outcome not specific to any one mental health diagnosis. The Global Severity Index (GSI) uses all three 6-item subscales (depression, anxiety, somatization), with a total raw score range of 0-72. Raw scores can be converted to T-scores using normative data. Higher scores indicate greater distress.

    Measured: Weeks 0 to 8, 24, and 40

  2. Patient Health Questionnaire-9 (PHQ-9)

    A 9-item self-report measure of depression symptom severity over the past 2 weeks. The total PHQ-9 score is the sum of all 9 items and can range from 0-27. Higher scores indicate greater depression symptom severity.

    Measured: Weeks 0 to 8, 24, and 40

  3. Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    A 20-item self-report measure of PTSD symptom severity over the past month. The total PCL-5 score is the sum of all 20 items and can range from 0-80. Higher scores indicate greater PTSD symptom severity.

    Measured: Weeks 0 to 8, 24, and 40

  4. Columbia Suicide Severity Rating Scale (C-SSRS) item 2

    This self-report item assesses suicidal ideation over the past month with yes or no response options. The full C-SSRS used in VHA will be administered, but this outcome focuses specifically on active suicidal ideation.

    Measured: Weeks 0 to 8, 24, and 40

  5. Frequency of Actions and Thoughts (FATS)

    An 12-item self-report measure of frequency of cognitive-behavioral therapy (CBT) skill utilization over the past week. This measure is sensitive to change from CBT self-help. The total FATS score is the sum of all 12 items (from 4 subscales) and can range from 0 to 48. Higher scores indicate greater frequency of CBT skill utilization.

    Measured: Weeks 0 to 8

  6. Recovery Support Services Utilization (RSSU)

    The investigators will use cumulative measures of utilization of 3 components across the 40-week study: (1) outpatient mental health treatment (a) within VHA and (b) outside VHA, (2) other relevant VHA whole-person health care, and (3) informal resources. See the other pre-specified outcomes with prefix RSSU below for details on measurement of each component.

    Measured: Weeks 0 to 40

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2025
  2. Study start1 Mar 2027 (estimated)
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion30 Aug 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized clinical trial in which participants are randomized to either the intervention condition (REST-V) or control (standard resources) condition.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07202325
Sponsor's protocol ID
RRD4-013-24W
Other IDs
RD000544
Status last verified
Aug 2026
First submitted
23 Sep 2025
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Final data sets underlying all publications resulting from the research may be shared outside VA. A Limited Dataset (LDS) that does not contain any personally identifiable information (PII) will be created and shared pursuant to a completed written Data Use Agreement (DUA) with the PI.

Questions about this trial

What is this clinical trial studying?

A study testing Resilience Training for Veterans (REST-V) and Usual resources in people with Depression and Stress Disorders, Post-Traumatic, run by VA Office of Research and Development at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Robyn L Shepardson, PhD ((315) 425-4400 ext. 53519, Robyn.Shepardson@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inventory of Psychosocial Functioning (IPF) (time frame: Weeks 0 to 8, 24, and 40). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in